Ossdsign AB (Publ) reported revenues for the period October - November 2023. For the period, company reported Preliminary total revenues amount to SEK 25.2 million, mainly attributable to a continued strong market performance of the orthobiologics franchise and some extraordinary orders from a large hospital system. According to preliminary and unaudited data, sales of OssDsign Catalyst amounted to SEK 18.8 million during the period of October - November 2023, whereas OssDsign Cranial recorded sales of SEK 6.4 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.75 SEK | +5.52% | +4.39% | +21.88% |
Apr. 15 | Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 15-APR-2024. | CI |
Apr. 02 | OssDsign Signs Three-year Supply Contract with Premier for Bone, Bone Substitute Products | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.88% | 82.3M | |
+13.16% | 128B | |
-8.76% | 10.65B | |
+3.60% | 8.82B | |
+19.75% | 7.19B | |
+22.28% | 4.99B | |
+7.55% | 3.4B | |
-0.21% | 3.03B | |
-4.80% | 2.14B | |
-4.72% | 2B |
- Stock Market
- Equities
- OSSD Stock
- News OssDsign AB
- Ossdsign AB Reports Revenues for the Period October - November 2023